Recent

% | $
Quotes you view appear here for quick access.

Exact Sciences Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • crapnebula crapnebula Dec 19, 2012 12:10 PM Flag

    RE: SQNM's Big Announcement This AM on FLY ON THE WALL

    Im sure you've noticed that they got approved for coverage in their target "at risk" group by Blue Cross this am (Wellpoint is the BC representative). Also, you fail to mention that SQNM is a company, that while not yet profitable has annual revenues in the hundreds of millions. The ONLY revenue EXAS has seen in its 10 years of history is that which came by way of their IPO and the multitude of secondary offerings in one form or another, not that this is unusual for a developmental stage company, but lets just get real here when comparing apple SEEDS to APPLES (whether you THINK they're crab apples or not, they ARE something you can see and hold right now).
    The SQNM announcement has not been released by the company to the main street press and I assume that it is their intention to let Wellpoint have the honors. At that time, you and I can both sit back and watch your old nemesis SQNM rise to 10.00 per share and 20.00 per share later this year.
    GLTA!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Your facts are distorted. Wellpoint noted limited coverage to some patients, they also listed 2 competitors they will also cover(limited) Exas has no real competitors. ttm revenue is only 71 million, not "HUNDREDS OF MILLIONS, and they show 150 million in debt.

      A reverse 3 for 1 split, 114 million shares out, book value .66 cents per share(EXAS 1.77)....nah, EXAS is a way better buy. Nice try, G/L.

      • 1 Reply to mstevens19600
      • Wellpoint noted NO SUCH THING LIAR MSTEVENS. (they haven't issued a press release yet, idiot). Please tell the board WTH you're smoking.
        Coverage is limited?? What do you mean? there are easily 1M births/pregnancies that will qualify coverage in the US alone. even if they penetrate 25% of that pool = 250,000 a year. Considering they will collect ~1500 per test = 250K X 1.5K = 375M revenue per year. If you consider a conservative multiple of 6X = 2.25B market cap or PPS of ~ $20 per share. If you don't understand the math then you are in the wrong business let alone your strategy here.
        My strong buy is for SQNM not this bloated junk stock EXAS

        Sentiment: Strong Buy

 
EXAS
21.980.00(0.00%)Apr 24 4:00 PMEDT